1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Asia Pacific Oligonucleotide Synthesis Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Asia Pacific Oligonucleotide Synthesis Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Demand for Personalized Medicine
5.2 Market Opportunities
- 5.2.1 Surging Investments and Advancements in DNA Synthesis by Oligonucleotide Synthesis Phosphoramidite Method
5.3 Future Trends
- 5.3.1 Strategic Initiatives by Market Players
5.4 Impact of Drivers and Restraints
6. Asia Pacific Oligonucleotide Synthesis Market Regional Analysis
6.1 Asia Pacific Oligonucleotide Synthesis Market Overview
6.2 Asia Pacific Oligonucleotide Synthesis Market Revenue 2016-2027 (US$ Million)
6.3 Asia Pacific Oligonucleotide Synthesis Market Forecast Analysis
7. Asia Pacific Oligonucleotide Synthesis Market Analysis – by Product
7.1 Synthesized Oligonucleotides
- 7.1.1 Overview
- 7.1.2 Synthesized Oligonucleotides: Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reagents
- 7.2.1 Overview
- 7.2.2 Reagents: Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Equipment
- 7.3.1 Overview
- 7.3.2 Equipment: Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2031 (US$ Million)
8. Asia Pacific Oligonucleotide Synthesis Market Analysis – by Application
8.1 Research
- 8.1.1 Overview
- 8.1.2 Research: Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Diagnostics
- 8.2.1 Overview
- 8.2.2 Diagnostics: Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Therapeutics
- 8.3.1 Overview
- 8.3.2 Therapeutics: Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
9. Asia Pacific Oligonucleotide Synthesis Market Analysis – by End User
9.1 Academic Research Institutes
- 9.1.1 Overview
- 9.1.2 Therapeutics: Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Pharmaceutical & Biotechnology Companies
- 9.2.1 Overview
- 9.2.2 Therapeutics: Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Therapeutics: Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Other End Users
- 9.4.1 Overview
- 9.4.2 Therapeutics: Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
10. Asia Pacific Oligonucleotide Synthesis Market – Asia-Pacific Analysis
10.1 Asia-Pacific
- 10.1.1 Asia Pacific Oligonucleotide Synthesis Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 10.1.1.1 Asia Pacific Oligonucleotide Synthesis Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 China:
Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 China: Asia Pacific Oligonucleotide Synthesis Market Breakdown, by Product
- 10.1.1.1.2 China: Asia Pacific Oligonucleotide Synthesis Market Breakdown, by Application
- 10.1.1.1.3 China: Asia Pacific Oligonucleotide Synthesis Market Breakdown, by End User
- 10.1.1.2 India:
Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 India: Asia Pacific Oligonucleotide Synthesis Market Breakdown, by Product
- 10.1.1.2.2 India: Asia Pacific Oligonucleotide Synthesis Market Breakdown, by Application
- 10.1.1.2.3 India: Asia Pacific Oligonucleotide Synthesis Market Breakdown, by End User
- 10.1.1.3 Japan:
Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 Japan: Asia Pacific Oligonucleotide Synthesis Market Breakdown, by Product
- 10.1.1.3.2 Japan: Asia Pacific Oligonucleotide Synthesis Market Breakdown, by Application
- 10.1.1.3.3 Japan: Asia Pacific Oligonucleotide Synthesis Market Breakdown, by End User
- 10.1.1.4 Australia:
Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.4.1 Australia: Asia Pacific Oligonucleotide Synthesis Market Breakdown, by Product
- 10.1.1.4.2 Australia: Asia Pacific Oligonucleotide Synthesis Market Breakdown, by Application
- 10.1.1.4.3 Australia: Asia Pacific Oligonucleotide Synthesis Market Breakdown, by End User
- 10.1.1.5 Rest of Asia-Pacific :
Asia Pacific Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Oligonucleotide Synthesis Market Breakdown, by Product
- 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Oligonucleotide Synthesis Market Breakdown, by Application
- 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Oligonucleotide Synthesis Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Asia Pacific Oligonucleotide Synthesis Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Molecular Assemblies
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Twist Bioscience
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Evonetix
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Nuclera Nucleics Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Camena Bio
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 DNA Script
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Iridia, Inc.,
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Helixworks
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Ansa Biotechnologies, Inc.,
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Synthomics, Inc.,
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights